Ling, F; Li, Z; Chen, E; Huang, Y; Tian, X; Schmullius, C; Leiterer, Reik; Reiche, J; Santoro, M (2012). Forest and non-forest mapping with envisat ASAR images. In: dragon 2 - dragon 3 symposium, Beijing, China, 25 June 2012 - 29 June 2012, 8 S..
Schmullius, C; Reiche, J; Leiterer, R; Cartus, O; Santoro, M; Wegmüller, U; Li, Z; Tian, X; Ling, F (2010). Forest Dragon 2: Mid-term results of the European partners. In: Symposium Dragon 2 Programme Mid-Term Results 2008–2010, Guilin City (China), 17 May 2010 - 21 May 2010, online.
Brabender, J; Arbab, D; Huan, X; Vallböhmer, D; Grimminger, P; Ling, F; Neiss, S; Bollschweiler, E; Schneider, P M; Hölscher, A H; Metzger, R (2009). Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Annals of Surgical Oncology, 16(5):1378-1383.
Hoffmann, A C; Brabender, J; Metzger, R; Ling, F; Warnecke-Eberz, U; Lurje, G; Hoelscher, A H; Schneider, P M; Vallböhmer, D (2009). Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection. Journal of Surgical Oncology, 99(5):296-301.
Hoffmann, A C; Vallböhmer, D; Prenzel, K; Metzger, R; Heitmann, M; Neiss, S; Ling, F; Hölscher, A H; Schneider, P M; Brabender, J (2009). Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. Journal of Cancer Research and Clinical Oncology, 135(9):1231-1237.